Found: 10
Select item for more details and to access through your institution.
The prognostic value of monosomal karyotype (MK) in higher‐risk patients with myelodysplastic syndromes treated with 5‐Azacitidine: A retrospective analysis of the Hellenic (Greek) Myelodysplastic syndromes Study Group.
- Published in:
- American Journal of Hematology, 2018, v. 93, n. 7, p. 895, doi. 10.1002/ajh.25111
- By:
- Publication type:
- Article
Bortezomib-based triplets are associated with a high probability of dialysis independence and rapid renal recovery in newly diagnosed myeloma patients with severe renal failure or those requiring dialysis.
- Published in:
- American Journal of Hematology, 2016, v. 91, n. 5, p. 499, doi. 10.1002/ajh.24335
- By:
- Publication type:
- Article
Early Relapse After Autologous Transplant Is Associated With Very Poor Survival and Identifies an Ultra-High-Risk Group of Patients With Myeloma.
- Published in:
- 2020
- By:
- Publication type:
- journal article
Outcomes of Consecutive Patients With Newly Diagnosed Myeloma Requiring Dialysis: Dialysis Independence is Associated with Rapid Myeloma Response and Predicts for Longer Survival.
- Published in:
- Clinical Lymphoma, Myeloma & Leukemia, 2017, v. 17, p. e62, doi. 10.1016/j.clml.2017.03.114
- By:
- Publication type:
- Article
Prior Lenalidomide Resistance and the Impact of IMiD-free Interval in Patients Treated with Pomalidomide and Dexamethasone.
- Published in:
- Clinical Lymphoma, Myeloma & Leukemia, 2017, v. 17, p. e115, doi. 10.1016/j.clml.2017.03.210
- By:
- Publication type:
- Article
The prognostic significance of chromosome 17 abnormalities in patients with myelodysplastic syndrome treated with 5‐azacytidine: Results from the Hellenic 5‐azacytidine registry.
- Published in:
- Cancer Medicine, 2019, v. 8, n. 5, p. 2056, doi. 10.1002/cam4.2090
- By:
- Publication type:
- Article
TLR4/TIRAP polymorphisms are associated with progression and survival of patients with symptomatic myeloma.
- Published in:
- British Journal of Haematology, 2016, v. 172, n. 1, p. 44, doi. 10.1111/bjh.13786
- By:
- Publication type:
- Article
Real‐life experience with the combination of polatuzumab vedotin, rituximab, and bendamustine in aggressive B‐cell lymphomas.
- Published in:
- Hematological Oncology, 2021, v. 39, n. 3, p. 336, doi. 10.1002/hon.2842
- By:
- Publication type:
- Article
The outcome of patients with high-risk MDS achieving stable disease after treatment with 5-azacytidine: A retrospective analysis of the Hellenic (Greek) MDS Study Group.
- Published in:
- 2018
- By:
- Publication type:
- journal article
Serum ferritin and ECOG performance status predict the response and improve the prognostic value of IPSS or IPSS-R in patients with high-risk myelodysplastic syndromes and oligoblastic acute myeloid leukemia treated with 5-azacytidine: a retrospective analysis of the Hellenic national registry of myelodysplastic and hypoplastic syndromes
- Published in:
- Therapeutic Advances in Hematology, 2020, v. 11, p. 1, doi. 10.1177/2040620720966121
- By:
- Publication type:
- Article